Overview

A Clinical Study of the Safety and Efficacy of MEBO Wound Ointment in Subjects With Diabetic Foot Ulcers

Status:
Completed
Trial end date:
2013-12-01
Target enrollment:
0
Participant gender:
All
Summary
The objective of this study is to evaluate the safety and efficacy of MEBO in the treatment of subjects with diabetic foot ulcers (DFUs).
Phase:
Phase 2
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
Skingenix, Inc.
Criteria
Inclusion Criteria:

- Male or female ≥18 years of age

- Able and willing to provide informed consent

- Able and willing to comply with protocol visits and procedures

- Target ulcer duration of ≥4 weeks

Exclusion Criteria:

- Ulcer of a non-diabetic pathophysiology

- Known or suspected allergies to any of the components of MEBO

- Malignancy on target ulcer foot

- Non-compliance in the screening or run-in period